These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 24224655)

  • 1. A novel urinary metabolite signature for diagnosing major depressive disorder.
    Zheng P; Chen JJ; Huang T; Wang MJ; Wang Y; Dong MX; Huang YJ; Zhou LK; Xie P
    J Proteome Res; 2013 Dec; 12(12):5904-11. PubMed ID: 24224655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
    Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
    J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder.
    Xu XJ; Zheng P; Ren GP; Liu ML; Mu J; Guo J; Cao D; Liu Z; Meng HQ; Xie P
    Mol Biosyst; 2014 Apr; 10(4):813-9. PubMed ID: 24457555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of urinary metabolite biomarkers for major depressive disorder.
    Zheng P; Wang Y; Chen L; Yang D; Meng H; Zhou D; Zhong J; Lei Y; Melgiri ND; Xie P
    Mol Cell Proteomics; 2013 Jan; 12(1):207-14. PubMed ID: 23111923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells.
    Liu ML; Zheng P; Liu Z; Xu Y; Mu J; Guo J; Huang T; Meng HQ; Xie P
    Mol Biosyst; 2014 Jul; 10(9):2398-406. PubMed ID: 24975926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary biomarker panel for diagnosing patients with depression and anxiety disorders.
    Chen JJ; Bai SJ; Li WW; Zhou CJ; Zheng P; Fang L; Wang HY; Liu YY; Xie P
    Transl Psychiatry; 2018 Sep; 8(1):192. PubMed ID: 30232320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Urinary Metabolite Signature for Non-invasive Post-stroke Depression Diagnosis.
    Zhang W; Zhang XA
    Cell Biochem Biophys; 2015 Jul; 72(3):661-7. PubMed ID: 27352185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells.
    Zheng P; Fang Z; Xu XJ; Liu ML; Du X; Zhang X; Wang H; Zhou J; Xie P
    J Affect Disord; 2016 May; 195():75-81. PubMed ID: 26874244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential urinary metabolites related with the severity of major depressive disorder.
    Chen JJ; Zhou CJ; Zheng P; Cheng K; Wang HY; Li J; Zeng L; Xie P
    Behav Brain Res; 2017 Aug; 332():280-287. PubMed ID: 28624318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of argininosuccinate synthase as a candidate urinary biomarker for major depressive disorder.
    Wu D; Peng Y; Zhou J; Yang YT; Rao CL; Bai SJ; Zhou XY; Chen J; Liao L; Liang ZH; Yang DY; Xie P
    Clin Chim Acta; 2015 Dec; 451(Pt B):142-8. PubMed ID: 26394130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct urinary metabolic profile of human colorectal cancer.
    Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
    J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
    Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
    Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of serum brain derived neurotrophic factor concentration in antidepressant naïve patients with first major depression episode.
    Karlović D; Serretti A; Jevtović S; Vrkić N; Serić V; Peleš AM
    J Psychiatr Res; 2013 Feb; 47(2):162-7. PubMed ID: 23102630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulations of amino acid metabolism and lipid metabolism in urine of children and adolescents with major depressive disorder: a case-control study.
    Jiang Y; Cai Y; Teng T; Wang X; Yin B; Li X; Yu Y; Liu X; Wang J; Wu H; He Y; Zhu ZJ; Zhou X
    Psychopharmacology (Berl); 2024 Aug; 241(8):1691-1703. PubMed ID: 38605232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of metabolomics-based urinary biomarker models for recognizing major depression disorder and bipolar disorder.
    Wang T; Yang J; Zhu Y; Niu N; Ding B; Wang P; Zhao H; Li N; Chao Y; Gao S; Dong X; Wang Z
    J Affect Disord; 2024 Jul; 356():1-12. PubMed ID: 38548210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC-MS-based metabonomics.
    Zheng P; Chen JJ; Zhou CJ; Zeng L; Li KW; Sun L; Liu ML; Zhu D; Liang ZH; Xie P
    Transl Psychiatry; 2016 Nov; 6(11):e955. PubMed ID: 27845778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma metabonomics as a novel diagnostic approach for major depressive disorder.
    Zheng P; Gao HC; Li Q; Shao WH; Zhang ML; Cheng K; Yang DY; Fan SH; Chen L; Fang L; Xie P
    J Proteome Res; 2012 Mar; 11(3):1741-8. PubMed ID: 22239730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
    J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
    Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
    J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Metabolomic Profiling to Identify Potential Biomarkers for the Diagnosis of Behcet's Disease by Gas Chromatography/Time-of-Flight-Mass Spectrometry.
    Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.